Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report

Non‐Hodgkin lymphoma can occur concurrently with chronic phase‐chronic myeloid leukemia (CML) at initial diagnosis. Combination treatment with second‐generation tyrosine kinase inhibitors and rituximab‐CHOP for patients newly diagnosed with CML and non‐Hodgkin lymphoma is effective for both diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeyasu, Yuki, Satake, Atsushi, Azuma, Yoshiko, Tsubokura, Yukie, Yoshimura, Hideaki, Hotta, Masaaki, Nakanishi, Takahisa, Fujita, Shinya, Nakaya, Aya, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715580/
https://www.ncbi.nlm.nih.gov/pubmed/29225854
http://dx.doi.org/10.1002/ccr3.1253
_version_ 1783283794401296384
author Takeyasu, Yuki
Satake, Atsushi
Azuma, Yoshiko
Tsubokura, Yukie
Yoshimura, Hideaki
Hotta, Masaaki
Nakanishi, Takahisa
Fujita, Shinya
Nakaya, Aya
Ito, Tomoki
Nomura, Shosaku
author_facet Takeyasu, Yuki
Satake, Atsushi
Azuma, Yoshiko
Tsubokura, Yukie
Yoshimura, Hideaki
Hotta, Masaaki
Nakanishi, Takahisa
Fujita, Shinya
Nakaya, Aya
Ito, Tomoki
Nomura, Shosaku
author_sort Takeyasu, Yuki
collection PubMed
description Non‐Hodgkin lymphoma can occur concurrently with chronic phase‐chronic myeloid leukemia (CML) at initial diagnosis. Combination treatment with second‐generation tyrosine kinase inhibitors and rituximab‐CHOP for patients newly diagnosed with CML and non‐Hodgkin lymphoma is effective for both diseases. However, we found that this treatment combination may induce severe myelosuppression.
format Online
Article
Text
id pubmed-5715580
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57155802017-12-08 Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report Takeyasu, Yuki Satake, Atsushi Azuma, Yoshiko Tsubokura, Yukie Yoshimura, Hideaki Hotta, Masaaki Nakanishi, Takahisa Fujita, Shinya Nakaya, Aya Ito, Tomoki Nomura, Shosaku Clin Case Rep Case Reports Non‐Hodgkin lymphoma can occur concurrently with chronic phase‐chronic myeloid leukemia (CML) at initial diagnosis. Combination treatment with second‐generation tyrosine kinase inhibitors and rituximab‐CHOP for patients newly diagnosed with CML and non‐Hodgkin lymphoma is effective for both diseases. However, we found that this treatment combination may induce severe myelosuppression. John Wiley and Sons Inc. 2017-11-02 /pmc/articles/PMC5715580/ /pubmed/29225854 http://dx.doi.org/10.1002/ccr3.1253 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Takeyasu, Yuki
Satake, Atsushi
Azuma, Yoshiko
Tsubokura, Yukie
Yoshimura, Hideaki
Hotta, Masaaki
Nakanishi, Takahisa
Fujita, Shinya
Nakaya, Aya
Ito, Tomoki
Nomura, Shosaku
Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title_full Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title_fullStr Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title_full_unstemmed Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title_short Tyrosine kinase inhibitor and rituximab‐CHOP treatment for concurrent chronic myeloid leukemia and non‐Hodgkin lymphoma: a case report
title_sort tyrosine kinase inhibitor and rituximab‐chop treatment for concurrent chronic myeloid leukemia and non‐hodgkin lymphoma: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715580/
https://www.ncbi.nlm.nih.gov/pubmed/29225854
http://dx.doi.org/10.1002/ccr3.1253
work_keys_str_mv AT takeyasuyuki tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT satakeatsushi tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT azumayoshiko tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT tsubokurayukie tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT yoshimurahideaki tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT hottamasaaki tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT nakanishitakahisa tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT fujitashinya tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT nakayaaya tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT itotomoki tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport
AT nomurashosaku tyrosinekinaseinhibitorandrituximabchoptreatmentforconcurrentchronicmyeloidleukemiaandnonhodgkinlymphomaacasereport

Ejemplares similares